FDA’s strategic priorities for 2018 is advancing digital health technologies
One of the priorities this year for the FDA is advancing digital health technologies. FDA’s Center for Devices and Radiological
Read MoreOne of the priorities this year for the FDA is advancing digital health technologies. FDA’s Center for Devices and Radiological
Read More(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read More(By Ike Swetlitz and Erin Mershon for STAT) WHITE OAK, Md. — The House is set to take up a
Read More(By Erin Mershon for STAT) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially blocking generic
Read More(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read More(By Lev Facher for STAT) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first time a
Read More(By Ike Swetlitz for STAT) WASHINGTON — The commissioner of the Food and Drug Administration, Scott Gottlieb, on Thursday suggested
Read More(By Lev Facher for STAT) WASHINGTON — With pressure building on the the Drug Enforcement Administration to stem the supply
Read More(By Chad Terhune for California Healthline produced by Kaiser Health News) In an ominous sign for patient safety, 71 percent
Read More(By Marisa Taylor for Kaiser Health News) The Food and Drug Administration has launched a criminal investigation into research by
Read More